IFIH1 antibody (N-Term)
Quick Overview for IFIH1 antibody (N-Term) (ABIN374329)
Target
See all IFIH1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Sequence
- SNGYSTDENF RYL-C
-
Specificity
- This antibody detects Helicard at N-term.
-
Cross-Reactivity (Details)
- Species reactivity (tested):Human.
-
Purification
- Ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide
-
Immunogen
- Peptide from N Terminus of the protein sequence according to NP_071451.2. Genename: IFIH1
-
-
-
-
Application Notes
- Peptide ELISA: Limit dilution 1: 32000. Immunohistochemistry: 10 μg/mL. In paraffin embedded Human Pancreas, shows strongcytoplasmic staining of some cells in the islets of Langerhans. In Western blot no signal obtained yet but low background observed in Human Placentalysate at up to 1 μg/mL.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 0.5 mg/mL
-
Buffer
- Tris saline, pH 7.3 containing 0.02 % Sodium Azide and 0.5 % BSA
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- IFIH1 (Interferon Induced with Helicase C Domain 1 (IFIH1))
-
Alternative Name
- Helicard
-
Background
- DEAD box proteins, characterized by the conserved motif Asp-Glu-Ala-Asp (DEAD), are putative RNA helicases. They are implicated in a number of cellular processes involving alteration of RNA secondary structure such as translation initiation, nuclear and mitochondrial splicing, and ribosome and spliceosome assembly. Based on their distribution patterns, some members of this family are believed to be involved in embryogenesis, spermatogenesis, and cellular growth and division. This gene encodes a DEAD box protein that is upregulated in response to treatment with beta-interferon (IFNB) and a protein kinase C-activating compound, mezerein (MEZ). Irreversible reprogramming of melanomas can be achieved by treatment with both these agents, treatment with either agent alone only achieves reversible differentiation. It is believed that MDA-5 may function to promote message degradation by specific RNases. It also seems to possess growth inhibition properties. The interaction of MDA5 with double stranded RNA can lead to induction of IFN required for the the innate immune response against viruses.Synonyms: Helicase with 2 CARD domains, IFIH1, Interferon-induced helicase C domain-containing protein 1, MDA5, Melanoma differentiation-associated protein 5, Murabutide down-regulated protein, RH116, RNA helicase-DEAD box protein 116
-
Gene ID
- 64135
-
NCBI Accession
- NP_071451
-
UniProt
- Q9BYX4
-
Pathways
- Activation of Innate immune Response
Target
-